| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K34485477 |
| PharmacoGx | BRD-K34485477 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABHD6 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.07 |
| mRNA | PROP1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | C14orf169 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | ARHGEF40 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.07 |
| mRNA | FAM65A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | TMED10 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | PDCD5 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | CRTC3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | ARPP19 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | TRIM23 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
